A new role for the renin-angiotensin system in ureteric bud branching

Organogenesis

Volumn 1, Issue 1, 2004, Pages 26-32

  Yosypiv, Ihor V ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Branching morphogenesis; Kidney development; Renin angiotensin; Stromal mesenchyme; Ureteric bud

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; BONE MORPHOGENETIC PROTEIN 4; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 10; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLYPICAN; NUCLEAR FACTOR I; OSTEOGENIC PROTEIN 1; PROTEIN P57; PROTEIN RET; RENIN; TRANSCRIPTION FACTOR PAX2; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BECKWITH WIEDEMANN SYNDROME; BRANCHING MORPHOGENESIS; BRANCHIOOTORENAL SYNDROME; COLOBOMA; CONTROLLED STUDY; EMBRYO; GENE MUTATION; GENETIC REGULATION; HYDRONEPHROSIS; IMMUNOHISTOCHEMISTRY; KALLMANN SYNDROME; KIDNEY CALYX; KIDNEY COLLECTING TUBULE; KIDNEY CONCENTRATING CAPACITY; KIDNEY DEVELOPMENT; KIDNEY FAILURE; KIDNEY PELVIS; MATURITY ONSET DIABETES MELLITUS; MESENCHYME; METANEPHROS; MOUSE; NONHUMAN; PRIMORDIUM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIMPSON GOLABI BEHMEL SYNDROME; TOWNES BROCKS SYNDROME; URETER; URETER BUD; URINARY TRACT MALFORMATION;

MAMMALIA;

EID: 19944377501     PISSN: 15476278     EISSN: None     Source Type: Journal    
DOI: 10.4161/org.1.1.1071     Document Type: Review

References (76)

1. rd edition. Baltimore: Williams & Wilkins, 1999:427-52.
2. Saxen L, Organogenesis of the kidney. Cambridge University Press, Cambridge, 1987.
3. Potter EL. Normal and abnormal developmet of the kidney. Year Book Medical Publishers Inc., Chicago, 1972.
4. Ekblom P. Developmentally regulated conversion of mesenchyme to epithelium. FASEB J 1989; 3:2141-50.
5. Yang J, Blum A, Novak T, Levinson R. An epithelial precursor is regulated by the ureteric bud and by the renal stroma. Dev Biology 2002; 246:296-310.
6. Hatini V, Huh SO, Herzlinger D, Soares VC, Lai E. Essential role of stromal mesenchyme in kidney morphogenesis revealed by targeted disruption of Winged Helix transcription factor BF-2. Genes Dev 1996; 10:1467-78.
7. Shawlot W, Behringer RR. Requirement for Lim1 in head-organizer function. Nature 1995; 374:425-30.
8. Dressier GR, Deutsch U, Chowdhury K, Nornes HO, Gruss P. Pax2, a new murine paired-box-containing gene and its expression in the developing excretoty system. Development 1990; 109:787-95.
9. Pelletier J, Schalling M, Buckler AJ, Rogers A, Haber DA, Housman D. Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev 1991; 5:1345-56.
10. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletir J, Housman D, et al. Wt1 is required for early kidney development. Cell 1993; 74:679-91.
11. Hellmich HL, Kos L, Cho ES, Mahon KA, Zimmer A. Embryonic expression of glial cell line derived neurotrophic factor (GDNF) suggests multiple developmental roles in neural differentiation and epithelial-mesenchymal interactions. Mech Dev 1996; 54:95-105.
12. Sariola H, Saarma M. GDNF and its receptors in the regulation of the ureteric branching. Int J Dev Biol 1999; 43:413-8.
13. Pachnis V, Mankoo B, Costantini F, Expression of the c-ret proto-oncogene during mouse development. Development 1993; 119:1005-17.
14. αs suggests novel roles for GDNF ligands during early organogenesis in the chick embryo. Dev Biol 2000; 217:121-37.
15. Xu PX, Adams J, Peters H, Brown MC, Heaney S, Maas R. Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet 1999; 23:113-7.
16. Nishinakamura R, Matsumoto Y, Nakao K, Nakamura K, Sato A, Copeland NG, et al. Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development. Development 2001; 128:3105-15.
17. Miyamoto N, Yoshida M, Kuratani S, Matsuo I, Aizawa S. Defects of urogenital development in mice lacking Emx2. Development 1997; 124:1653-64.
18. Maas R, Elfering S, Glaser T, Jepeal L. Deficient outgrowth of the ureteric bud underlies the renal agenesis phenotype in mice manifesting the limb deformity (Id) mutation. Dev Dyn 1994; 199:214-28.
19. Muller U, Wang D, Denda S, Meneses JJ, Pedersen RA, Reichardt LF, Integrin α8β1 is critically important for epithelial-mesenchymal interactions during kidney morphogenesis. Cell 1977; 88:603-13.
20. Lin Y, Liu A, Zhang S, Ruusunen T, Kreiberg JA, Peltoketo H, et al. Induction of ureter branching as a response to Wnt-2b signaling during early kidney organogenesis. Dev Dynamics 2001; 222:26-39.
21. Stark K, Vainio S, Vassileva G, and McMahon AP. Epithelial transformation of metanephric mesenchyme in the developing kidney is regulated by Wnt-4. Nature 1994; 372:679-83.
22. Dudley A, Lyons K, Robertson EJ. A requirement for bone morphogenic protein-7 during development of the mammalian kidney and eye. Genes Dev 1995; 9:2795-807.
23. Luo G, Hofmann C, Bronckers ALJJ, Sohochi M, Bradley A, Karsenty G. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 1995; 9:2808-20.
24. Patterson LT, Pembaur M, Potter SS. Hoxal 1 and Hoxdl 1 regulate branching morphogenesis of the ureteric bud in the developing kidney. Development 2001; 128:2153-61.
25. Qiao J, Uzzo R, Obara-Ishihara T, Degenstein L, Fuchs E, Herzlinger D. FGF-7 modulates ureteric bud growth and nephron number in the developing kidney. Development 1999; 126:547-54.
26. Ohuchi H, Hori Y, Yamasaki M, Harada H, Sekine K, Kato S, et al. FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem Biophys Res Commun 2000; 277:643-49.
27. Santos OFP, Barros EJG, Yang XM, Matsumoco K, Nakamura T, Park M, et al. Involvement of hepatocyte growth factor in kidney development. Dev Biol 1994; 163:525-9.
28. Barros EJG, Santos OFP, Matsumoto K, Nakamura T, Nigam SK. Differential tubulogenic and branching morphogeneric activities of growth factors: implications for epithelial tissue development. Proc Natl Acad Sci USA 1995; 92:4412-6.
29. Sakurai H, Nigam SK. Transforming growth factor-β selectively inhibits branching morphogenesis but not tubulogenesis. Am J Physiol 1997; 272:F139-46.
30. Sakurai H, Bush KT, Nigam SK. Identification of pleiotrophin as a mesenchymal factor involved in ureteric bud branching morphogenesis. Development 2001; 128:3283-93.
31. Cano-Gauci DF, Song H, Yang H, McKerlie C, Choo B, Iackova I, et al. Glypican 3-deficient mice exhibit developmental overgrowth and some of the renal abnormalities typical of Simpson-Golabi-Behmel syndrome. J Cell Biol 1999; 146:255-64.
32. KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 1997; 387:151-8.
33. Miyazaki Y, Oshima K, Fogo A, Hogan BL, Ichikawa I. Bone morphogenic protein 4 regulates the budding site and elongation of the mouse ureter. J Clin Invest 2000; 105:863-73.
34. Finch PW, Cunha GR, Rubin JS, Wong J, Ron D. Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions. Dev Dyn 1995; 203:223-40.
35. Mendelsohn C, Batourina E, Fung S, Gilbert T, Dodd J. Stromal cells mediate retinoid-dependent functions essential for renal development. Development 1999; 126:1139-48.
36. Batourina E, Gim S, Bello N, Shy M, Clagett-Dame M, Srinivas S, et al. Vitamin A controls epithelial/mesenchymal interactions through Ret expression. Nature Genet 2001; 27:74-8.
37. Batourina E, Choi C, Paragas N, Bello N, Hensle T, Costantini FD, et al. Distal ureter morphogenesis depends on epithelial cell remodeling mediated by vitamin A and Ret. Nature Genetics 2002; 32:109-15.
38. Quaggin SE, Schwartz L, Cui S, Igarashi P, Deimling J, Post M, et al. The basic helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development 1999; 126:5771-83.
39. Cui S, Schwartz L, Quaggin SE. Pod1 is required in stromal cells for glomerulogenesis. Dev Dynamics 2003; 226:512-22.
40. Chitayat D, Hodgkinson KA, Chen MY, Haber GD, Nakishima S, Sando I. Branchio-otorenal syndtome: further delineation of the underdiagnosed syndrome. Am J Med Genet 1992; 43:970-5.
41. Sanyanusin P, Schimmenti LA, McNoe LA, Ward TA, Pierpont MEM, Sullivan MJ, et al. Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nat Genet 1995; 9:358-64.
42. Hardelin JP. Kallman syndrome: towards molecular pathogenesis. Mol Cell Endocrinol 2001; 179:75-81.
43. Iwasaki N, Okabe I, Momoi MY, Ohashi H, Ogata M, Iwamoto Y. Splice site mutation in the hepatocyte nuclear factor-1β gene, IVS2nt + IG > A, associated with maturity-onset diabetes of the young, renal dysplasia and bicornuate uterus. Diabetologia 2001; 44:387-8.
44. O'Callaghan M, Young ID. Townes-Brocks syndrome. J Med Genet 1990; 27:457-61.
45. Verloes A, Massart B, Dehalleux I, Langhendries JP, Koulischer L. Clinical overlap of Beckwith-Wiedemann, Perlman and Simpson-Golabi-Behmel syndromes: a diagnostic pitfall. Clin Genet 1995; 47:257-62.
46. Elliot M, Bayly R, Cole T, Temple IK, Maher ER. Clinical features and natural history of Beckwith-Wiedemann syndrome: presentation of 74 new cases. Clin Genet 1994; 46:168-74.
47. Arima S, Kohagura K, Abe M, Ito S. Mechanisms that control glomerular hemodynamics. Clin Exp Nephrol 2001; 5:55-61.
48. Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG. Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol 2001; 281:H2337-65.
49. Wolf G, Haberstroh U, Neilson EG. Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 1992; 140:95-107.
50. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 1997; 100:264-9.
51. 2 receptor. Kidney Int 2000; 57:191-202.
52. Goto M, Mukoyama M, Suga, Matsumoto T, Nakagawa M, Ishibashi R, et al. Growth-dependent induction of angiotensin II type 2 receptor in rat mesangial cells. Hypertension 1997; 30:358-62.
53. Tufro-McReddie A, Romano LM, Harris JM, Ferder L, Gomez RA. Angiotensin II regulates nephrogenesis and renal vascular development. Am J Physiol 1995; 38:F110-5.
54. Nagata M, Tanimoto K, Fukamizu A, Kon Y, Sugiyama F, Yagami K, et al. Nephrogenesis and renovascular development in angiotensinogen-deficient mice. Lab Invest 1996; 75:745-53.
55. 1B receptors for angiotensin II. Proc Natl Acad Sci USA 1998; 95:15496-501.
56. Esther CR, Howard TE, Marino EM, Goddard JM, Capecchi MR, Bernstein KE. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 1996; 74:953-65.
57. Gomez RA, Lynch KR, Sturgill BC, Elwood JP, Chevalier RL, Carey RM, et al. Distribution of renin mRNA and its protein in the developing kidney. Am J Physiol 1989; 257:F850-8.
58. Norwood VF, Craig MR, Harris JM, Gomez RA. Differential expression of angiotensin II receptors during early renal morphogenesis. Am J Physiol 1997; 272:R662-8.
59. Yosipiv IV, Dipp S, El-Dahr SS. Ontogeny of somatic angiotensin- converting enzyme. Hypertension 1994; 23:369-74.
60. Yosipiv IV, El-Dahr SS. Activation of angiotensin-generating systems in the developing kidney. Hypertension 1996; 27:281-6.
61. Kakuchi J, Ichiki T, Kiyama S, Hogan BLM, Fogo A, Inagami T, et al. Developmental expression of renal angiotensin II receptor genes in the mouse. Kidney Int 1995; 47:140-7.
62. 1 receptors. Physiol Genomics 2001; 6:29-37.
63. 1 receptors in ureteric bud cell branching. Am J Physiol 2003; 285:F199-207.
64. Lopez ML, Pentz ES, Robert B, Abrahamson DR, Gomez RA. Embryonic origin and lineage of juxtaglomerular cells. Am J Physiol 2001; 281:F345-56.
65. Qiao J, Bush KT, Steer DL, Stuart RO, Sakurai H, Wachsman W, et al. Multiple fibroblast growth factors support growth of the ureteric bud but have different effects on branching morphogenesis. Mechanisms of Development 2001; 109:123-35.
66. Stirling D, Magness RR, Stone R, Waterman MR, Simpson ER, Angiotensin II inhibits luteinizing hormone-stimulated cholesterol side chain cleavage expression and stimulates basic fibroblast growth factor expression in bovine luteal cells in primary culture. J Biol Chem 1990; 265:5-8.
67. Miyazaki Y, Tsuchida S, Nishimura H, Pope JC, Harris RC, McKanna JM, et al. Angiotensin Induces the urinary peristaltic machinery during the perinatal period. J Clin Invest 1998; 102:1489-97.
68. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995; 95:651-7.
69. 2) during murine organogenesis. J Invest Med 2002; 50:134A.
70. Oshima K, Miyazaki Y, Brock JW, Adams MC, Ichikawa I, Pope JC. Angiotensin type II receptor expression and ureteral budding. J Urology 2001; 166:1848-52.
71. Huwiler A, Stabel S, Fabbro D, Pfeilschifter. Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: comparison of hypertrophic and hyperplastic agonists. Biochem J 1995; 305:777-84).
72. Saward, L, Zahradka P. Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ Res 1997; 81:249-57.
73. Schorb W, Peeler TC, Madigan NN, Conrad KM, Baker KM. Angiotensin II-induced protein tyrosine phosphorylation in neonatal rat cardiac fibroblasts. J Biol Chem 1994; 269:19626-32.
74. Weiner ID, New AR, Milton AE, Tisher CC. Regulation of luminal alkalinization and acidification in the cortical collecting duct by angiotensin II. Am J Physiol 1995; 269:F730-8.
75. +-ATPase activity in rat cortical collecting duct. Am J Physiol 1994; 267:F1045-51.
76. Wei Y, Wang W. Angiotensin II stimulates basolateral K channels in rat cortical collecting ducts. Am J Physiol 2003; 284:F175-81.